Epilepsy in women

Mayo Clinic Proceedings

Volumn 71, Issue 10, 1996, Pages 991-999

  Shuster, Elizabeth A ^a  

^a Mayo Clinic Jacksonville   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CYTOCHROME P450; FELBAMATE; GABAPENTIN; LAMOTRIGINE; ORAL CONTRACEPTIVE AGENT; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID;

CONFERENCE PAPER; DISEASE PREDISPOSITION; DRUG ABSORPTION; DRUG CHOICE; DRUG CLEARANCE; DRUG ELIMINATION; DRUG PROTEIN BINDING; EPILEPSY; FETOTOXICITY; HUMAN; MENSTRUAL CYCLE; PREGNANCY; TREATMENT PLANNING;

EID: 0030317090     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-6196(11)63775-0     Document Type: Article

References (60)

1. Logothetis J, Harner R. Electrocortical activation by estrogens. ArchNeurol 1960; 3:290-297
2. Her/og AG. Clomiphene therapy in epileptic women with menstrual disorders. Neurology 1988; 38:432-434
3. Herzog AG. Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders. Neurology 1986; 36:1607-1610
4. Morrell MJ. Hormones and epilepsy through the lifetime. Epilepsia 1992; 33(Suppl 4):S49-S61
5. Uthman BM, Wilder BJ. Less commonly used antiepileptic drugs. In: Wyllie E, editor. The Treatment of Epilepsy: Principles and Practice. Philadelphia: Lea & Febiger, 1993: 959-973
6. Herzog AG. Reproductive endocrine considerations and hormonal therapy for women with epilepsy. Epilepsia 1991; 32(Suppl 6):S27-S33
7. Abbasi F, Krumholz A, Kittner S, Langenberg P. Effects of menopause on women with epilepsy [abstract]. Epilepsia 1995;36(Suppl4):148
8. Diamantopoulos N, Crumrine PK. The effect of puberty on the course of epilepsy. Arch Neurol 1986; 43:873-876
9. Herzog AG, Seibel MM, Schomer DL, Vaitukaitis JL, Geschwind N. Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch Neurol 1986; 43:341-346
10. Demerdash A, Shaalan M, Midani A, Kamel F, Bahri M. Sexual behavior of a sample of females with epilepsy. Epilepsia 1991; 32:82-85
11. Bilo L, Meo R, Nappi C, Annunziato L, Striano S, Colao AM, et al. Reproductive endocrine disorders in women with primary generalized epilepsy. Epilepsia 1988; 29:612-619
12. Webber MP, Hauser WA, Ottman R, Annegers JF. Fertility in persons with epilepsy: 1935-1974. Epilepsia 1986; 27:746-752
13. Dansky LV, Andermann E, Andermann F. Marriage and fertility in epileptic patients. Epilepsia 1980; 21:261-271
14. Nappi C, Meo R, Di Carlo C, Estraneo A, Bilo L. Reduced fertility and neuroendocrine dysfunction in women with epilepsy. Gynecol Endocrinol 1994; 8:133-145
15. Cramer JA, Jones EE. Reproductive function in epilepsy. Epilepsia 1991; 32(Suppl 6):S19-S26
16. Morrell MJ. Sexual dysfunction in epilepsy. Epilepsia 1991; 32(Suppl 6):S38-S45
17. Isojarvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllyla VV. Menstrual disorders in women with epilepsy receiving carbamazepine. Epilepsia 1995; 36:676-681
18. Krauss GL, Brandt J, Campbell M, Plate C. Reproductive issues in epilepsy are poorly understood by U.S. neurologists and obstetricians [abstract]. Epilepsia 1995; 36(Suppl 3):S12
19. Mattson RH, Cramer JA, Darney PD, Naftolin F. Use of oral contraceptives by women with epilepsy. JAMA 1986; 256:238-240
20. Perucca E, Hedges A, Makki KA, Ruprah M, Wilson JF, Richens A. A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients. Br J Clin Pharmacol 1984; 18:401-410
21. Knight AH, Rhind EG. Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia 1975; 16:99-110
22. Schmidt D, Ganger R, Avanzini G, Battino D, Cusi C, BeckMannagetta G, et al. Changes of seizure frequency in pregnant epileptic women. J Neurol Neurosurg Psychiatry 1983; 46:751-755
23. Lopez-Cendes I, Andermann E, Cendes F, Dansky L, Andermann F. Risk factors for changes in seizure frequency during pregnancy of epileptic women: a cohort study [abstract]. Epilepsia 1992; 33(Suppl 3):57
24. Yerby MS. Treatment of epilepsy during pregnancy. In: Wyllie E, editor. The Treatment of Epilepsy: Principles and Practice. Philadelphia: Lea & Febiger, 1993: 844-857
25. Hiilesmaa VK, Bardy A, Teramo K. Obstetric outcome in women with epilepsy. Am J Obstet Gynecol 1985; 152:499504
26. Teramo K, Hiilesmaa VK. Pregnancy and fetal complications in epileptic pregnancies: review of the literature. In:
27. Janz D, Dam M, Richens A, Bossi L, Helge H, Schmidt D, editors. Epilepsy, Pregnancy, and the Child. New York: Raven Press, 1982:53-59
28. Yerby MS, Freil PN, McCormick K. Antiepileptic drug disposition during pregnancy. Neurology 1992; 42(Suppl 5): 12-16
29. Hiilesmaa VK. Pregnancy and birth in women with epilepsy. Neurology 1992; 42(Suppl 5):8-l 1
30. Delgado-Escueta A, Janz D. Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology 1992; 42(Suppl 5): 149160
31. Gumnit RJ. The Epilepsy Handbook: The Practical Management of Seizures. 2nd ed. New York: Raven Press, 1995
32. Commission on Genetics, Pregnancy, and the Child, International League Against Epilepsy. Guidelines for the care of women of childbearing age with epilepsy. Epilepsia 1993; 34:588-589
33. German J, Kowal A, Ehler KH. Trimethadione and human teratogenesis. Teratology 1970; 3:349-362
34. Nakane Y, Okuma T, Takahashi R, Sato Y, Wada T, Sato T, et al. Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan. Epilepsia 1980; 21:663-680
35. Waters CH, Belai Y, Gott PS, Shen P, De Giorgio CM. Outcomes of pregnancy associated with antiepileptic drugs. Arch Neurol 1994; 51:250-253
36. Battino D, Binelli S, Caccamo ME, Canevini MP, Ganger R, Como ME, et al. Malformations in offspring of 305 epileptic women: a prospective study. Acta Neurol Scand 1992; 85:204-207
37. Kaneko S, Battino D, Andermann E, Multicenter Collaborative Study Groups. Congenital malformations in offspring of mothers with epilepsy [abstract]. Epilepsia 1995; 36(Suppl 3):S11
38. Holmes EB, Harvey EA, Brown KS, Hayes AM, Khoshbin S. Anticonvulsant teratogenesis. I. A study design for newborn infants. Teratology 1994:49:202-207
39. Dravet C, Julian C, Eegras C, Magaudda A, Guerrini R, Genton P, et al. Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study. Neurology 1992; 42(Suppl 5):7582
40. Robert E, Guilbaud P. Maternal valproic acid and congenital neural tube defects [letter]. Eancet 1982; 2:937
41. Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991; 324:674-677
42. Eindhout D, Omtzigt JG. Pregnancy and the risk of teratogenicity. Epilepsia 1992; 33(Suppl 4):S41-S48
43. Dansky EV, Rosenblatt DS, Andermann E. Mechanisms of teratogenesis: folic acid and antiepileptic therapy. Neurology 1992;42(Suppl5):32-42
44. Finnell RH, Buehler BA, Kerr BM, Ager PL, Eevy RH. Clinical and experimental studies linking oxidative metabo-lism to phenytoin-induced teratogenesis. Neurology 1992; 42(Suppl5):25-31
45. Richens A. Safety of lamotrigine. Epilepsia 1994; 35(Suppl 5):S37-S40
46. McLeanMJ. Gabapentin. Epilepsia 1995; 36(Suppl 2):S73S86
47. Yerby MS. Risks of pregnancy in women with epilepsy. Epilepsia 1992; 33(Suppl 1):S23-S26
48. Cornelissen M, Steegers-Theunissen R, Kollee L, Eskes T, Motohara K, Monnens L. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency. Am J Obstet Gynecol 1993; 168:884-888
49. Jensen P, Jensen SB, Sorensen PS, Bjerre BD, Rizzi DA, Sorensen AS, et al. Sexual dysfunction in male and female patients with epilepsy: a study of 86 outpatients. Arch Sex Behav 1990; 19:1-14
50. Morrell MJ, Sperling M, Stecker M, Dichter M. Sexual dysfunction in partial epilepsy: a deficit in physiological sexual arousal [abstract]. Neurology 1991; 41(Suppl 1):298
51. Schraeder PL, Schraeder BD, Rossi-Schwartz R, Noguchi L. Sexual and physical abuse in women with epilepsy [abstract]. Epilepsia 1994; 35(Suppl 8):S57
52. Sheth RD, Penney S, Jacob JC, Wesolowski CA, Hobbs GR. Valproate reduces bone density in children with idiopathic epilepsy [abstract]. Epilepsia 1994; 35(Suppl 8):S35
53. Chung S, Ahn C. Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children. Brain Dev 1994; 16:382-385
54. Collins N, Mäher J, Cole M, Baker M, Callaghan N. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia. QJM 1991; 78:113-122
55. Rico H, Varela de Seijas E, Arias JA, Cabranes JA. Longterm influence of anticonvulsant agents on calcitonin, parathyroid hormone and osteocalcin. Eur Neurol 1992; 32:324327
56. Sander JW, Patsalos PN. An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapy. Epilepsy Res 1992; 13:89-92
57. Swart E, Lochner JD. Skin conditions in epileptics. Clin Exp Dermatol 1992; 17:169-172
58. Walshe MM. Cutaneous drug effects in epilepsy. Trans St Johns Hosp Dermatol Soc 1972; 58:269-281
59. Isojärvi JI, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KT, Myllylä VV. Hyperandrogenism and polycystic ovaries are associated with obesity and hyperinsulinemia in women treated with valproate for epilepsy [abstract]. Epilepsia 1995;36(Suppl3):S68
60. Gidal BE, Anderson GD, Spencer NW, Maly M, Murty J, Pitterle M, et al. Valproic acid (VPA) associated weight gain in monotherapy patients with epilepsy [abstract]. Epilepsia 1994; 35(Suppl8):S142